What were Intuitive Surgical's Q2 2026 results?

Financial figures have not been disclosed yet, but management noted continued global adoption of its robotic platforms despite a U.S. procedure slowdown.

How did ISRG stock perform after the call?

The stock saw little change, as investors await the full financial details.

What challenges does Intuitive Surgical face?

The company faces a slowdown in U.S. procedure growth and ongoing challenges in the Chinese market.

Intuitive Surgical Q2 2026: Global Robotic Platform Adoption Continues

Q: Did the company provide guidance?

No specific numerical guidance was given, but the company reiterated its commitment to increasing adoption of its robotic platforms.

Intuitive Surgical (ISRG) reported Q2 2026 results, highlighting continued global adoption of da Vinci and Ion platforms despite U.S. procedure slowdown and China challenges.

Intuitive Surgical (NASDAQ:ISRG) reported its second quarter 2026 financial results, with management pointing to continued global adoption of its da Vinci, da Vinci SP, and Ion robotic platforms. Despite a moderation in U.S. procedure growth and ongoing challenges in China, CEO Dave Rosa stated that underlying demand remains strong.

Key Financial Results

Metric	Q2 2026	YoY Change
Revenue	Not yet disclosed	-
Net Income	Not yet disclosed	-
EPS	Not yet disclosed	-

Note: The call did not include specific financial figures; these will be released in the full quarterly report.

Key Highlights

Management noted that global procedure growth remained positive but slowed in the U.S. The company continues to expand internationally, though China remains challenging due to regulatory and economic factors.

Guidance

No specific numerical guidance was provided during the call, but the company reiterated its commitment to increasing adoption of its robotic platforms through innovation and geographic expansion.

Stock Impact

ISRG stock saw little change following the call, as investors await the full financial details. The stock is currently trading near previous levels.

What This Means for Investors

Intuitive Surgical's long-term growth momentum appears intact, but near-term headwinds from U.S. slowdown and China challenges may temper growth. Investors should review the full quarterly report for a clearer picture.